New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Dr. Reddy's Laboratories Limited
RDY
Shape
US Flag

NYSE

13B

Drug Manufacturers - Specialty & Generic

Next Earning date - 28 Jan 2025

13B

Drug Manufacturers - Specialty & Generic

Next Earning date - 28 Jan 2025

78.44USD
Shape2.06 ( 2.70%)
favorite-chart

Relative Strenght

50
favorite-chart

Volume Buzz

-18%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

7%

Quote Panel

Shape
Updated October 29, 2024
1W 0.32 % 1M -1.41 % 3M -2.85 % 1Y 21.54 %

Key Metrics

Shape
  • Market Cap

    13.07B


  • Shares Outstanding

    32.87M


  • Share in Float

    32.87M


  • Dividende

    0.48


  • Earning Date

    28 Jan 2025


  • Price Target

    78.44


  • Average Volume

    177600


  • Beta

    0.312


  • Range

    63.72-84.46


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.drreddys.com


  • Sector

    Healthcare


Fundamentals

Shape

19.58x

P/E Ratio

3.76x

P/S Ratio

3.69x

P/B Ratio

0.1

Debt/Equity

19.3%

Net Margin

$0.8

EPS

How RDY compares to sector?

P/E Ratio

Relative Strength

Shape

RDY

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$312B

Shape306%

2025-Revenue

$339.31

Shape306%

2025-EPS

$95B

Shape338%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+3%

0.82
vs 0.8

Q4.22

arrow
arrow

+60%

0.91
vs 0.57

Q1.23

arrow
arrow

+32%

0.7
vs 0.53

Q2.23

arrow
arrow

+14%

1.03
vs 0.9

Q3.23

arrow
arrow

+30%

1.07
vs 0.82

Q4.23

arrow
arrow

+9%

0.99
vs 0.91

Q1.24

arrow
arrow

+34%

0.94
vs 0.7

Q2.24

arrow
arrow

-3%

1
vs 1.03

Q3.24

arrow
arrow

+7918%

85.8
vs 1.07

Q4.24

arrow
arrow

+8647%

86.59
vs 0.99

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+9%

63.1B  vs 57.6B

Q4.22

arrow
arrow

+27%

67.7B  vs 53.2B

Q1.23

arrow
arrow

+16%

63B  vs 54.4B

Q2.23

arrow
arrow

+29%

67.4B  vs 52.2B

Q3.23

arrow
arrow

+9%

68.8B  vs 63.1B

Q4.23

arrow
arrow

+7%

72.1B  vs 67.7B

Q1.24

arrow
arrow

+12%

70.8B  vs 63B

Q2.24

arrow
arrow

+14%

76.7B  vs 67.4B

Q3.24

arrow
arrow

+12%

76.9B  vs 68.8B

Q4.24

arrow
arrow

+10%

79.3B  vs 72.1B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+5%

0.05
vs 0.06

Q4.22

arrow
arrow

+6%

0.06
vs 0.05

Q1.23

arrow
arrow

+4%

0.04
vs 0.06

Q2.23

arrow
arrow

+6%

0.06
vs 0.04

Q3.23

arrow
arrow

+6%

0.06
vs 0.06

Q4.23

arrow
arrow

+5%

0.05
vs 0.06

Q1.24

arrow
arrow

+5%

0.05
vs 0.05

Q2.24

arrow
arrow

+5%

0.05
vs 0.05

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

150

150
vs 149

1%

Q4.22

arrow
arrow

164

164
vs 150

9%

Q1.23

arrow
arrow

192

192
vs 164

17%

Q2.23

arrow
arrow

195

195
vs 192

2%

Q3.23

arrow
arrow

215

215
vs 195

10%

Q4.23

arrow
arrow

223

223
vs 215

4%

Q1.24

arrow
arrow

236

236
vs 223

6%

Q2.24

arrow
arrow

218

218
vs 236

-8%

Earnings Growth

Latest News